Jean Lefebvre
- Formation
- à venir
Aucune offre active
Autres opportunités de carrière
- Axe principal
- Métabolisme, santé vasculaire et rénale
- Adresse
- 2705, boulevard Laurier, C-00118
Québec (Québec)
CANADA G1V 4G2 - Téléphone
- +1 418-525-4444, poste 48118
- Télécopieur
- +1 418-654-2759
- Courriel
- Jean.Lefebvre@crchul.ulaval.ca
Publications récentes (voir toutes les publications de ce chercheur)
Lacourciere Y, Poirier L, Lefebvre J, Ross SA, Leenen FH. Increasing the doses of both diuretics and angiotensin receptor blockers is beneficial in subjects with uncontrolled systolic hypertension. The Canadian journal of cardiology,
2010. 26: 313-9
LeFebvre J, Shintani A, Gebretsadik T, Petro JR, Murphey LJ, Brown NJ. Bradykinin B(2) receptor does not contribute to blood pressure lowering during AT(1) receptor blockade. The Journal of pharmacology and experimental therapeutics,
2007. 320: 1261-7
Lefebvre J, Poirier L, Poirier P, Turgeon J, Lacourciere Y. The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertension. British journal of clinical pharmacology,
2007. 63: 575-82
Lacourciere Y, Lefebvre J, Poirier L, Cote C, Dumont M. [Frequency and severity of silent ischemia, as detected by stress dipyridamole TC-99M sestamibi spect imaging in patients with hypertension and atherogenic risk factor.] Archives des maladies du coeur et des vaisseaux,
2007. 100: 677-8
Lacourciere Y, Cote C, Lefebvre J, Poirier L, Dumont M. Identifying Which Treated Hypertensive Patients Without Known Coronary Artery Disease Should Be Tested for the Presence of Myocardial Ischemia by Perfusion Imaging. Journal of clinical hypertension (Greenwich, Conn.),
2007. 9: 921-928
Lacourciere Y, Poirier L, Lefebvre J. Expedited blood pressure control with initial angiotensin II antagonist/diuretic therapy compared with stepped-care therapy in patients with ambulatory systolic hypertension. The Canadian journal of cardiology,
2007. 23: 377-82
Lefebvre J, Poirier L, Tirman G. Monitoring ambulatoire de la tension des 24 heures L’actualité pharmaceutique,
2006. 14: S1 (6 pages)
Lacourcière Y, Côté C, Lefebvre J, Dumont M. Noninvasive detection of silent coronary artery disease in patients with essential hypertension, alone or associated with type 2 diabetes mellitus, using dipyridamole stress 99mtechnetium-sestamibi myocardial perfusion imaging.
The Canadian journal of cardiology,
2006. 22: 16-21
Vachon A, Lefebvre J. Mise à jour sur le traitement des dyslipidémies (1re partie) Québec Pharmacie,
2006. 54: 31-37
Vachon A, Lefebvre J. Mise à jour sur le traitement des dyslipidémies (2e partie) Québec Pharmacie,
2006. 54: 35-40
